Corporate Strategy
What makes us different?
Capstone is uniquely well-positioned to advise corporate clients in highly regulated industries. Our core policy analysis capabilities allow us to create value-added growth strategies, whether organic or acquisition-focused. We provide corporate clients with real-time and forward-looking policy analyses of legislative and executive branch actions that could present opportunities or create challenges. With our broad range of due diligence capabilities, our unique and varied public policy and industry relationships, and our propensity to go deeper in the weeds than anyone else, we are an ideal partner to help you solve complex policy and regulatory challenges.
We live in the weeds.
Our team leverages our deep and diverse policy subject matter expertise and our relationships with industry groups, regulators, policymakers, and third-party advocates to analyze the risk profile of corporate strategies and potential investments and create actionable best practices to mitigate risk and find opportunities.
Capital and Corporate Strategy
- Advise clients on acquisitions in highly regulated industries
- Provide comprehensive regulatory due diligence for acquisitions
- Advise on capital raises
- Industry analysis
- Consumer patterns and concerns
Policy and Political Analysis
- Provide access for corporate leadership to senior policymakers, including trips to Washington, DC for in-person meetings
- Provide real-time analysis of key political and policy changes with detailed analysis of industry impact
- International regulatory agency analysis and risk analysis
- Political risk audits
- Sanctions review
Connect with us
Our Latest Insights
Congressional Response to Russia’s Ukraine Invasion Narrows to Energy Policy
By: Daniel Silverberg March 28, 2022 As the war in Ukraine rages on, Capstone believes Congress has largely spent its sanctions bullets and will have to settle for smaller legislation that codifies what the administration has already done as well as other symbolic...
From Death Panels to Duopoly: How Dialysis Coverage has Changed & Looming Risks for Providers
By: Grace Totman March 27, 2022 When the dialysis procedure was invented in the 1940s, patients with chronic kidney disease could finally breathe a sigh of relief. A cure—or at least a long-term treatment option—was, at last, available. What was less clear was how it...
Antitrust: Congressional Snail versus the Enforcement Tortoise
By: Ian Tang March 22, 2022 — For the last few years, technology policy has been defined by policymakers’ aggressive approach to antitrust enforcement—both at the state and federal levels. From increased enforcement funding and tougher merger review processes to a ban...